Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patients will receive standard card alone.
Checked against the public recordLast updated Jul 18, 2019 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 4
- Sponsor
- New York City Health and Hospitals Corporation
- Interventions being studied
- Drug: budesonide, beclomethasone
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Chief complaint consistent with asthma exacerbation * Previous diagnosis of asthma by a physician OR one major in the Asthma Predictive Index (API) with two prior episodes of wheezing in the past year. * Major criteria in the API: parent with asthma, patient with eczema, evidence of sensitization to allergens in the air * Received oral corticosteroids as part of treatment during this visit for acute asthma exacerbation. * Deemed well enough after interventions to be discharged by the treating physician. * If \<5 years of age, possession of nebulizer machine at home. Exclusion Criteria: * Received asthma controller medications within four weeks prior to presentation * Allergy to intervention asthma controller medications.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Kings County Hospital CenterBrooklyn, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 18, 2019. Always confirm current availability with the study team.